Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Don't Worry: Marijuana Investing in 2017 Will Be Even Better Than 2016

By any measure, 2016 was a great year – a watershed, in fact – for the tech- and pharma-heavy cannabis niche.

For instance, ever since Sept. 2, when I sent my paid-up Nova-X Report readers the 30 pot stock recommendations in my "weed investors' bible," The Roadmap to Marijuana Millions, we've seen incredible gains all across the market sector.

And what had been a phenomenal year got even better with a massive victory: In November, voters in five states (read, five juicy untapped markets) voted to legalize medical and recreational marijuana. That boosted the cannabis niche's growth prospects immensely. Remember, this is an investing arena that was already expected to grow by more than 31% a year until at least the early 2020s.

But… the buoyant marijuana markets took notice when the president-elect tapped Sen. Jeff Sessions (R-AL) to be the next U.S. attorney general. The nation's would-be top cop is known for his, shall we say, "retrograde" views on marijuana – legal and otherwise.

That news cast a great deal of uncertainty on investments with an otherwise vertical trajectory.

So, naturally, pot stock investors are wondering what the future might hold for this high-growth, immensely profitable investing niche.

Well, I'm going to show you a glimpse of that future right now. It still looks as bright and profitable as it ever did…

There's Not Much Sessions Can Do to Dampen Cannabis

Like I said, Senator Sessions isn't known for his bullish, forward-looking view of marijuana. In fact, he's an outspoken critic.

In an April U.S. Senate meeting, for instance, Sessions said, "We need grown-ups in charge in Washington to say marijuana is not the kind of thing that ought to be legalized."

He also said in the same meeting that "good people don't smoke marijuana."

Still, it's quite a stretch to think that, even in his new position of power, Sessions will be able to effect the kind of massive public policy overhaul it would take to revoke legalization.

Currently, marijuana is illegal under federal law. But because of a congressional rule from 2014, the U.S. Department of Justice (DoJ) is not allowed to use funds to interfere with the implementation of state cannabis laws.

Also, a recent Aug. 16 court ruling states the Justice Department can no longer prosecute medical marijuana businesses where the defendants are following state laws.

Fundamentally, this means one certain thing: Marijuana legalization is determined by state voters right now.

And it's highly likely to stay that way.

I'm confident of that assertion because of what Donald Trump himself has been telegraphing so far.

From a policy perspective, the president-elect is on the record saying marijuana policy is something best left to the states.

What's more, the president has no power to nullify state laws, and only Congress has the power to pass federal laws. As it stands, Congress's attitude toward marijuana is likely to reflect the U.S. electorate.

And that view has changed radically over the last 20 years.

Most Americans – about 60% of them, in fact – now favor legalizing marijuana according to recent polls. With legalization's popularity continuing to climb, it's highly unlikely Congress will vote against legalization going forward.

marijuana investing in 2017

In fact, there are several bills working their way through Congress that could further ease legalization.

For example, the Marijuana Business Access to Banking Act would update federal banking rules to resolve conflicts between federal and state laws and allow banks and credit unions to provide services to legitimate marijuana businesses.

So the truth is, despite the juicy, scary headlines touting the "new Drug War" Trump and Sessions are "planning," the debate over marijuana legalization is larger, by far, than one presidential administration.

In fact, considering all of these political developments, there's one extremely bullish reason investing in marijuana stocks will remain profitable even with Sessions as Attorney General…

My 2017 Cannabis Outlook: Extremely Bullish

Join the conversation. Click here to jump to comments…

About the Author

Michael A. Robinson is one of the top financial analysts working today. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.

Read full bio

  1. martin wenke | January 7, 2017

    I believe u are correct on this

  2. bharathy | January 7, 2017

    it is better legal there and also medicine for patient of the hospitals
    better we claim billion dollars from the business . we scope the business on legal there . here is restrict in law of india how it possible legal in there nation really surprise

    good day and good movement ( we wait for your scope)

  3. Rob Vik | January 27, 2017

    Love to hear more of MJ investing.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK